TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
St1 Biokraft AB
Closing information (x1000 NOK)
Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Turnover |
451,640
|
346,875
|
384,063 |
Financial expenses |
117,351
|
55,798
|
61,166 |
Earnings before taxes |
-174,602
|
-90,211
|
-44,359 |
EBITDA |
22,686
|
17,770
|
87,105 |
Total assets |
1,987,182
|
1,772,766
|
1,612,195 |
Current assets |
448,709
|
614,254
|
539,271 |
Current liabilities |
356,060
|
243,646
|
216,160 |
Equity capital |
587,484
|
702,666
|
494,073 |
- share capital |
88,294
|
82,444
|
59,554 |
Employees (average) |
115
|
105
|
109 |
Financial ratios
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Solvency |
29.6%
|
39.6%
|
30.6% |
Turnover per employee |
3,927
|
3,304
|
3,524 |
Profit as a percentage of turnover |
-38.7%
|
-26.0%
|
-11.5% |
Return on assets (ROA) |
-2.9%
|
-1.9%
|
1.0% |
Current ratio |
126.0%
|
252.1%
|
249.5% |
Return on equity (ROE) |
-29.7%
|
-12.8%
|
-9.0% |
Change turnover |
80,152
|
-25,646
|
54,061 |
Change turnover % |
22%
|
-7%
|
16% |
Chg. No. of employees |
10
|
-4
|
30 |
Chg. No. of employees % |
10%
|
-4%
|
38% |
Total value of public sale
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.